2.9700
+0.2300
+(8.39%)
At close: 4:00:01 PM EDT
3.0793
+0.11
+(3.68%)
After hours: 5:43:19 PM EDT
Insider Roster
Insider roster data is derived solely from the last 24 months of Form 3 & Form 4 SEC filings.
| Individual or Entity | Most Recent Transaction | Date | Shares Owned as of Transaction Date |
|---|---|---|---|
| BROADFOOT JILL MARIE Chief Financial Officer | Sale | Feb 4, 2025 | 31,763 |
| CLARKE JOHN K. Director | Conversion of Exercise of derivative security | Apr 26, 2023 | 19,797 |
| COUGHLIN TIMOTHY P Director | Purchase | May 30, 2024 | -- |
| DENYES NANCY General Counsel | Sale | Feb 4, 2025 | 26,555 |
| GROSS JANE A Director | Purchase | Mar 17, 2025 | 9,750 |
| LUCAS SVETLANA Director | Conversion of Exercise of derivative security | Apr 26, 2023 | 6,000 |
| SCHIMMEL PAUL R Director | Purchase | Jul 24, 2024 | -- |
| SHUKLA SANJAY S Chief Executive Officer | Conversion of Exercise of derivative security | Feb 3, 2025 | 146,923 |
| ZAKNOEN SARA Director | Conversion of Exercise of derivative security | Apr 26, 2023 | 6,000 |
Related Tickers
NKTR Nektar Therapeutics
0.6177
+23.76%
LRMR Larimar Therapeutics, Inc.
1.8100
+1.69%
LXEO Lexeo Therapeutics, Inc.
1.9800
-8.76%
CMPX Compass Therapeutics, Inc.
1.6950
+2.73%
RCKT Rocket Pharmaceuticals, Inc.
5.27
+6.68%
SGMT Sagimet Biosciences Inc.
2.3100
+3.59%
SRRK Scholar Rock Holding Corporation
28.00
+6.42%
INZY Inozyme Pharma, Inc.
0.8861
+0.61%
IOVA Iovance Biotherapeutics, Inc.
3.3000
+7.84%
TRVI Trevi Therapeutics, Inc.
5.56
+5.30%